1. Short title This Act may be cited as the FDA Cosmetic Safety and Modernization Act . 2. Adverse event reporting (a) In general Subchapter H of chapter VII of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379aa et seq.) is amended by adding at the end the following: 762. Serious adverse event reporting for cosmetics (a) Definitions In this section: (1) The term adverse event means any health-related event associated with the use of a cosmetic that is adverse. (2) The term serious adverse event means an adverse event that— (A) results in— (i) death; (ii) a life-threatening experience; (iii) inpatient hospitalization; (iv) a persistent or significant disability, incapacity, or disfigurement; (v) a congenital abnormality or birth defect; or (vi) permanent alteration of appearance other than as intended, under conditions of use that are customary or usual